Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema.
about
Biomarkers of World Trade Center particulate matter exposure: physiology of distal airway and blood biomarkers that predict FEV1 declineEarly elevation of serum MMP-3 and MMP-12 predicts protection from World Trade Center-lung injury in New York City firefighters: a nested case-control studyChallenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsRespiratory syncytial virus infections enhance cigarette smoke induced COPD in miceRelationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysisFEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure.Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 productionCompartment differences of inflammatory activity in chronic obstructive pulmonary diseaseType-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors.Elevated Matrix Metalloproteinase Levels in Bronchi Infected with Periodontopathogenic BacteriaRelationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases.Variability in proteinase-antiproteinase balance, nutritional status, and quality of life in stable chronic obstructive pulmonary disease due to tobacco and nontobacco etiology.Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?Cathepsin G degradation of phospholipid transfer protein (PLTP) augments pulmonary inflammation.Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease.Metalloproteinases and Their Tissue Inhibitors in Comparison between Different Chronic Pneumopathies in the Horse.Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD.Role of inflammatory cells in airway remodeling in COPDThe correlation of age and body mass index with the level of both protease MMP3 and anti-protease TIMP-1 among Indonesian patients with chronic obstructive pulmonary disease: a preliminary findings
P2860
Q23918414-19E163DF-ABE9-4C63-917F-E27C94E9C5F3Q23921517-A42940F3-EC4E-4064-B28F-F10F4144F639Q26766294-2106301C-9A16-41EC-BEA5-64A329B94767Q27317947-0C79304D-4ACD-4322-800A-7C069DA5482CQ28076457-1AA08842-76BA-4BE2-ABF0-969D94E77435Q33863052-1FE04196-80CB-4F85-BCC6-A4716941A001Q33898616-57AABAA5-1A65-4F2E-9A8E-899E0A65F7C5Q34570194-245C2B2F-A4CF-47A6-A45B-5AA4B7FC59FAQ34716819-838BB44C-3347-47BF-86E5-EC47FF6994E8Q35866106-843EBA25-886B-4BB7-9FD4-22314CFD004DQ36961473-E4FDA7C7-450E-4C13-BE0A-2A088F823238Q37129533-AF6B9300-7906-4806-BEB4-D0AF0E62A4E2Q37419622-4D306047-7881-427D-96B1-84EC5AB6C6C7Q37521554-C23B7EC3-FFCA-4E2C-A53C-4506D48E4841Q37702957-7135D7C4-D9BE-43E1-92F5-24809F65C0ADQ38649641-8E4B366C-84BC-4A3D-B684-B85F1CB78E39Q43125830-DBE9D2FF-187A-46B0-B412-C27152DB8B81Q47988448-90F9F308-7D56-404F-A4D5-7109458B1192Q48092527-34BCA393-5898-4930-B688-4F42CA52A6CCQ57815421-11B872F0-0BA7-4D1D-A31D-FD6CCDD9DC94Q58803905-108D87EF-D054-4226-9CA9-690314B6C184
P2860
Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Increased matrix metalloprotei ...... y or progression in emphysema.
@ast
Increased matrix metalloprotei ...... y or progression in emphysema.
@en
type
label
Increased matrix metalloprotei ...... y or progression in emphysema.
@ast
Increased matrix metalloprotei ...... y or progression in emphysema.
@en
prefLabel
Increased matrix metalloprotei ...... y or progression in emphysema.
@ast
Increased matrix metalloprotei ...... y or progression in emphysema.
@en
P2093
P2860
P50
P1433
P1476
Increased matrix metalloprotei ...... y or progression in emphysema.
@en
P2093
Andrew A Hardigan
Andrew J Ghio
Jeanine M D'Armiento
Jincy Thankachen
John E Connett
Michael D Roth
Monirul Islam
Patrick Geraghty
Robert F Foronjy
Steven M Scharf
P2860
P304
P356
10.1371/JOURNAL.PONE.0056352
P407
P577
2013-02-18T00:00:00Z